Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Frampton

Showing results (91-100 of 133) with videos related to

Pageof 14
Sort By:
Rheumatology (Oxford, England)|April 28, 2012
Furosemide increases plasma oxypurinol without lowering serum urate--a complex drug interaction: implications for clinical practiceLisa K Stamp, Murray L Barclay, John L O'Donnell, et al.
BMC Medical Education|September 2, 2016
Assessing the similarity of mental models of operating room team members and implications for patient safety: a prospective, replicated studyIvana Nakarada-Kordic, Jennifer M Weller, Craig S Webster, et al.
Arthritis Research & Therapy|December 23, 2017
The effect of kidney function on the urate lowering effect and safety of increasing allopurinol above doses based on creatinine clearance: a post hoc analysis of a randomized controlled trialLisa K Stamp, Peter T Chapman, Murray Barclay, et al.
Rheumatology (Oxford, England)|August 15, 2018
Can we predict inadequate response to allopurinol dose escalation? Analysis of a randomised controlled trialLisa K Stamp, Peter T Chapman, Murray Barclay, et al.
Arthritis and Rheumatism|August 1, 2009
Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatmentLisa K Stamp, John L O'Donnell, Peter T Chapman, et al.
BJS Open|August 5, 2023
Consensus-defined sarcopenia predicts adverse outcomes after elective abdominal surgery: meta-analysisBrittany Park, Sameer Bhat, Weisi Xia, et al.
Arthritis and Rheumatism|February 1, 2011
Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairmentLisa K Stamp, John L O'Donnell, Mei Zhang, et al.
Arthritis Research & Therapy|November 25, 2015
Association between environmental exposures and granulomatosis with polyangiitis in Canterbury, New ZealandLisa K Stamp, Peter T Chapman, Janine Francis, et al.
Arthritis and Rheumatism|January 30, 2010
Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapyLisa K Stamp, John L O'Donnell, Peter T Chapman, et al.
Arthritis Research & Therapy|November 18, 2018
How much allopurinol does it take to get to target urate? Comparison of actual dose with creatinine clearance-based doseLisa K Stamp, Peter T Chapman, Murray L Barclay, et al.
Pageof 14

Showing results (91-100 of 133) with videos related to

Sort By:
Pageof 14
Rheumatology (Oxford, England)|April 28, 2012
Furosemide increases plasma oxypurinol without lowering serum urate--a complex drug interaction: implications for clinical practiceLisa K Stamp, Murray L Barclay, John L O'Donnell, et al.
BMC Medical Education|September 2, 2016
Assessing the similarity of mental models of operating room team members and implications for patient safety: a prospective, replicated studyIvana Nakarada-Kordic, Jennifer M Weller, Craig S Webster, et al.
Arthritis Research & Therapy|December 23, 2017
The effect of kidney function on the urate lowering effect and safety of increasing allopurinol above doses based on creatinine clearance: a post hoc analysis of a randomized controlled trialLisa K Stamp, Peter T Chapman, Murray Barclay, et al.
Rheumatology (Oxford, England)|August 15, 2018
Can we predict inadequate response to allopurinol dose escalation? Analysis of a randomised controlled trialLisa K Stamp, Peter T Chapman, Murray Barclay, et al.
Arthritis and Rheumatism|August 1, 2009
Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatmentLisa K Stamp, John L O'Donnell, Peter T Chapman, et al.
BJS Open|August 5, 2023
Consensus-defined sarcopenia predicts adverse outcomes after elective abdominal surgery: meta-analysisBrittany Park, Sameer Bhat, Weisi Xia, et al.
Arthritis and Rheumatism|February 1, 2011
Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairmentLisa K Stamp, John L O'Donnell, Mei Zhang, et al.
Arthritis Research & Therapy|November 25, 2015
Association between environmental exposures and granulomatosis with polyangiitis in Canterbury, New ZealandLisa K Stamp, Peter T Chapman, Janine Francis, et al.
Arthritis and Rheumatism|January 30, 2010
Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapyLisa K Stamp, John L O'Donnell, Peter T Chapman, et al.
Arthritis Research & Therapy|November 18, 2018
How much allopurinol does it take to get to target urate? Comparison of actual dose with creatinine clearance-based doseLisa K Stamp, Peter T Chapman, Murray L Barclay, et al.
Pageof 14